Business Description
TransThera Sciences is a clinical-stage pharmaceutical company based in Nanjing, China, focused on developing oral small molecule drugs to treat cancer, inflammatory conditions, and metabolic diseases. Its pipeline includes several promising compounds at various stages of clinical development, with its lead drug Tinengotinib currently being tested in patients with hard-to-treat solid tumors. The company works alongside partners Neurocrine Biosciences and Akeso to advance treatments for additional conditions, including liver cancer. Founded in 2014, TransThera has built a broad and diverse portfolio targeting some of today's most challenging medical conditions.
